FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077286010> ?p ?o ?g. }

• W2077286010 endingPage "17184" @default.
• W2077286010 startingPage "17178" @default.
• W2077286010 abstract "The regioselectivity for progesterone hydroxylation by cytochrome P450 2B1 was re-engineered based on the x-ray crystal structure of cytochrome P450 2C5. 2B1 is a highKm progesterone 16α-hydroxylase, whereas 2C5 is a low Km progesterone 21-hydroxylase. Initially, nine individual 2B1 active-site residues were changed to the corresponding 2C5 residues, and the mutants were purified from an Escherichia coli expression system and assayed for progesterone hydroxylation. At 150 ॖm progesterone, I114A, F297G, and V363L showed 5–157 of the 21-hydroxylase activity of 2C5, whereas F206V showed high activity for an unknown product and a 13-fold decrease in Km. Therefore, a quadruple mutant, I114A/F206V/F297G/V363L (Q), was constructed that showed 607 of 2C5 progesterone 21-hydroxylase activity and 577 regioselectivity. Based on their 2C5-like testosterone hydroxylation profiles, S294D and I477F alone and in combination were added to the quadruple mutant. All three mutants showed enhanced regioselectivity (707) for progesterone 21-hydroxylation, whereas only Q/I477F had a higherkcat. Finally, the remaining three single mutants, V103I, V367L, and G478V, were added to Q/I477F and Q/S294D/I477F, yielding seven additional multiple mutants. Among these, Q/V103I/S294D/I477F showed the highest kcat(3-fold higher than that of 2C5) and 807 regioselectivity for progesterone 21-hydroxylation. Docking of progesterone into a three-dimensional model of this mutant indicated that 21-hydroxylation is favored. In conclusion, a systematic approach to convert P450 regioselectivity across subfamilies suggests that active-site residues are mainly responsible for regioselectivity differences between 2B1 and 2C5 and validates the reliability of 2B1 models based on the crystal structure of 2C5. The regioselectivity for progesterone hydroxylation by cytochrome P450 2B1 was re-engineered based on the x-ray crystal structure of cytochrome P450 2C5. 2B1 is a highKm progesterone 16α-hydroxylase, whereas 2C5 is a low Km progesterone 21-hydroxylase. Initially, nine individual 2B1 active-site residues were changed to the corresponding 2C5 residues, and the mutants were purified from an Escherichia coli expression system and assayed for progesterone hydroxylation. At 150 ॖm progesterone, I114A, F297G, and V363L showed 5–157 of the 21-hydroxylase activity of 2C5, whereas F206V showed high activity for an unknown product and a 13-fold decrease in Km. Therefore, a quadruple mutant, I114A/F206V/F297G/V363L (Q), was constructed that showed 607 of 2C5 progesterone 21-hydroxylase activity and 577 regioselectivity. Based on their 2C5-like testosterone hydroxylation profiles, S294D and I477F alone and in combination were added to the quadruple mutant. All three mutants showed enhanced regioselectivity (707) for progesterone 21-hydroxylation, whereas only Q/I477F had a higherkcat. Finally, the remaining three single mutants, V103I, V367L, and G478V, were added to Q/I477F and Q/S294D/I477F, yielding seven additional multiple mutants. Among these, Q/V103I/S294D/I477F showed the highest kcat(3-fold higher than that of 2C5) and 807 regioselectivity for progesterone 21-hydroxylation. Docking of progesterone into a three-dimensional model of this mutant indicated that 21-hydroxylation is favored. In conclusion, a systematic approach to convert P450 regioselectivity across subfamilies suggests that active-site residues are mainly responsible for regioselectivity differences between 2B1 and 2C5 and validates the reliability of 2B1 models based on the crystal structure of 2C5. substrate recognition sites Until the recent elucidation of the rabbit cytochrome P450 2C5 x-ray crystal structure (1Williams P.A. Cosme J. Sridhar V. Johnson E.F. McRee D.E. Mol. Cell. 2000; 5: 121-131Abstract Full Text Full Text PDF PubMed Scopus (710) Google Scholar), chimeragenesis, site-directed mutagenesis, and homology modeling based on bacterial structures have been the primary tools available to identify key residues responsible for the substrate specificities of mammalian P450 enzymes (2Domanski T.L. Halpert J.R. Curr. Drug Metab. 2001; 2: 117-137Crossref PubMed Scopus (153) Google Scholar). Most of these residues belong to the substrate recognition sites (SRSs)1 proposed by Gotoh (3Gotoh O. J. Biol. Chem. 1992; 267: 83-90Abstract Full Text PDF PubMed Google Scholar) based on analogy with the crystal structure of bacterial P450 101 and have direct counterparts in the active site of P450 2C5. However, most P450 structures reveal that the heme group is buried deep within the protein matrix, indicating that residues outside of the active site may also be required to guide the substrate into the heme pocket by recognizing substrates at the protein surface and/or comprising part of a substrate access channel (4Haseman C.A. Kurumbail R.G. Boddupalli S.S. Peterson J.A. Deisenhofer J. Structure. 1995; 3: 41-62Abstract Full Text Full Text PDF PubMed Scopus (642) Google Scholar, 5Graham-Lorence S. Peterson J.A. FASEB J. 1996; 10: 206-214Crossref PubMed Scopus (124) Google Scholar, 6Waller C.L. Evans M.V. McKinney J.D. Drug Metab. Dispos. 1996; 2: 203-210Google Scholar). The role of SRS and non-SRS residues in differential substrate specificity and stereo- and regioselectivity within P450 subfamilies has been studied thoroughly, especially in the case of P450 2A, 2B, and 2C enzymes. In most cases, the functions of the enzymes could be interconverted by making multiple reciprocal substitutions at SRS residues (7He Y.Q. Szklarz G.D. Halpert J.R. Arch. Biochem. Biophys. 1996; 335: 152-160Crossref PubMed Scopus (31) Google Scholar, 8Strobel S.M. Halpert J.R. Biochemistry. 1997; 36: 11697-11706Crossref PubMed Scopus (25) Google Scholar, 9Negishi M. Uno T. Honkakoski P. Sueyoshi T. Darden T. Pedersen L.P. Biochimie (Paris). 1996; 78: 685-694Crossref PubMed Scopus (21) Google Scholar, 10Goldstein J.A. de Morais S.M. Pharmacogenetics. 1994; 4: 285-299Crossref PubMed Scopus (519) Google Scholar). However, in a number of other studies, non-SRS residues were shown to play a crucial role in determining substrate specificities (11Hoch U. Falck J.R. Ortiz de Montellano P.R. J. Biol. Chem. 2000; 275: 26952-26958Abstract Full Text Full Text PDF PubMed Google Scholar, 12Domanski T.L. Schultz K.M. Roussel F. Stevens J.C. Halpert J.R. J. Pharmacol. Exp. Ther. 1999; 290: 1141-1147PubMed Google Scholar, 13He Y.Q. Harlow G.R. Szklarz G.D. Halpert J.R. Arch. Biochem. Biophys. 1998; 350: 333-339Crossref PubMed Scopus (25) Google Scholar, 14Ibeanu G.C. Ghanayem B.I. Linko P. Li L. Pederson L.G. Goldstein J.A. J. Biol. Chem. 1996; 271: 12496-12501Abstract Full Text Full Text PDF PubMed Scopus (91) Google Scholar, 15Pikuleva I. Puchkaev A. Bjorkhem I. Biochemistry. 2001; 40: 7621-7629Crossref PubMed Scopus (36) Google Scholar, 16Nakayama K. Puchkaev A. Pikuleva I. J. Biol. Chem. 2001; 276: 31459-31465Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar, 17Tsao C.C. Wester M.R. Ghanayem B. Coulter S.J. Chanas B. Johnson E.F. Goldstein J.A. Biochemistry. 2001; 40: 1937-1944Crossref PubMed Scopus (48) Google Scholar). These non-SRS residues were predicted to be part of a substrate access channel near a region between the F and G helices, as seen in bacterial P450 101, or between the B-C loop and N terminus of the I helix, as seen in bacterial P450 51 (18Poulos T.L. Cupp-Vickery J. Li H. Ortiz de Montellano P.R. Cytochrome P450: Structure, Mechanism, and Biochemistry. Plenum Press, New York1995: 125-150Crossref Google Scholar, 19Poulos T.L. Finzel B.C. Gunsalus I.C. Wagner G.C. Kraut J. J. Biol. Chem. 1985; 260: 16122-16130Abstract Full Text PDF PubMed Google Scholar, 20Podust L.M. Poulos T.L. Waterman M.R. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 3068-3073Crossref PubMed Scopus (484) Google Scholar). The mammalian P450 2C5 structure supports the existence of both substrate access channels (1Williams P.A. Cosme J. Sridhar V. Johnson E.F. McRee D.E. Mol. Cell. 2000; 5: 121-131Abstract Full Text Full Text PDF PubMed Scopus (710) Google Scholar). Structure-function studies across P450 subfamilies have been largely neglected until very recently (21Luo Z. He Y.A. Halpert J.R. Arch. Biochem. Biophys. 1994; 309: 52-57Crossref PubMed Scopus (48) Google Scholar, 22Spatzenegger M. Liu H. Wang Q. Debarber A. Koop D.R. Halpert J.R. J. Pharmacol. Exp. Ther. 2003; 304: 477-487Crossref PubMed Scopus (65) Google Scholar). Renewed interest in this area was sparked by the considerable effort in a number of laboratories to use the P450 2C5 structure to model other mammalian P450 enzymes and to predict their substrate specificities and stereo- and regioselectivity (2Domanski T.L. Halpert J.R. Curr. Drug Metab. 2001; 2: 117-137Crossref PubMed Scopus (153) Google Scholar, 23Afzelius L. Zamora I. Ridderström M. Andersson T.B. Karlén A. Masimirembwa C.M. Mol. Pharmacol. 2001; 59: 909-919Crossref PubMed Scopus (120) Google Scholar, 24Spatzenegger M. Wang Q. He Y.Q. Wester M.R. Johnson E.F. Halpert J.R. Mol. Pharmacol. 2001; 59: 475-484Crossref PubMed Scopus (44) Google Scholar, 25Lewis D.F.V. J. Inorg. Biochem. 2002; 91: 502-514Crossref PubMed Scopus (33) Google Scholar). An implicit assumption in all such models based on a single template is that the backbones of the enzymes are essentially invariant and that active-site differences alone are responsible for specificity differences. In this study, we sought to confer the progesterone hydroxylation specificity of 2C5 on 2B1. 2B1 is a highKm progesterone 16α-hydroxylase, whereas 2C5 is a low Km progesterone 21-hydroxylase (26Cosme J. Johnson E.F. J. Biol. Chem. 2000; 275: 2545-2553Abstract Full Text Full Text PDF PubMed Scopus (160) Google Scholar). 2B1 was used as a model enzyme because of extensive previous site-directed mutagenesis studies that have verified experimentally all 13 active-site residues inferred from the 2C5 structure (2Domanski T.L. Halpert J.R. Curr. Drug Metab. 2001; 2: 117-137Crossref PubMed Scopus (153) Google Scholar, 21Luo Z. He Y.A. Halpert J.R. Arch. Biochem. Biophys. 1994; 309: 52-57Crossref PubMed Scopus (48) Google Scholar, 27Kedzie K.M. Balfour C.A. Escobar G.Y. Grimm S.W. He Y.A. Pepperl D.J. Regan J.W. Stevens J.C. Halpert J.R. J. Biol. Chem. 1991; 266: 22515-22521Abstract Full Text PDF PubMed Google Scholar, 28Halpert J.R. He Y.A. J. Biol. Chem. 1993; 268: 4453-4457Abstract Full Text PDF PubMed Google Scholar, 29He Y.A. Luo Z. Klekotka P.A. Burnett V.L. Halpert J.R. Biochemistry. 1994; 33: 4419-4424Crossref PubMed Scopus (81) Google Scholar, 30Szklarz G.D. He Y.A. Halpert J.R. Biochemistry. 1995; 34: 14312-14322Crossref PubMed Scopus (96) Google Scholar, 31Kobayashi Y. Strobel S.M. Hopkins N.E. Alworth W.L. Halpert J.R. Drug Metab. Dispos. 1998; 26: 1026-1030PubMed Google Scholar, 32Domanski T.L. He Y.Q. Scott E.E. Wang Q. Halpert J.R. Arch. Biochem. Biophys. 2001; 394: 21-28Crossref PubMed Scopus (29) Google Scholar). Through a systematic approach of site-directed mutagenesis, a 2B1 enzyme (V103I/I114A/F206V/S294D/F297G/V363L/I477F) was constructed that showed a 3-fold higher kcat compared with 2C5 and 807 regioselectivity for progesterone 21-hydroxylation. The results suggest a dominant role of active-site side chains in determining regioselectivity differences across these two P450 subfamilies and extend previous evidence for the reliability of 2B models based on the 2C5 structure (24Spatzenegger M. Wang Q. He Y.Q. Wester M.R. Johnson E.F. Halpert J.R. Mol. Pharmacol. 2001; 59: 475-484Crossref PubMed Scopus (44) Google Scholar). Oligonucleotide primers were obtained from the University of Texas Medical Branch Molecular Biology Core Laboratory. [4-14C]Progesterone and [4-14C]testosterone were obtained from PerkinElmer Life Sciences and Amersham Biosciences), respectively. All other chemicals were purchased from sources previously described (33Scott E.E. Spatzenegger M. Halpert J.R. Arch. Biochem. Biophys. 2001; 395: 57-68Crossref PubMed Scopus (126) Google Scholar) or from standard suppliers. Rat NADPH-cytochrome P450 reductase and cytochromeb5 were prepared as described (34Harlow G.R. He Y.A. Halpert J.R Biochim. Biophys. Acta. 1997; 1338: 259-266Crossref PubMed Scopus (30) Google Scholar). The truncated version of 2B1 that served as the background for all mutations described in this study, 2B1dH, was generated using overlap extension PCR as described (33Scott E.E. Spatzenegger M. Halpert J.R. Arch. Biochem. Biophys. 2001; 395: 57-68Crossref PubMed Scopus (126) Google Scholar). Mutants were constructed either by overlap extension PCR or by subcloning using pKK2B1dH as a template. The primers and templates used are shown in Fig. 1. Primary forward and reverse primers were as previously described (33Scott E.E. Spatzenegger M. Halpert J.R. Arch. Biochem. Biophys. 2001; 395: 57-68Crossref PubMed Scopus (126) Google Scholar). To confirm the desired mutation and to verify the absence of unintended mutations, all constructs were sequenced at the University of Texas Medical Branch Protein Chemistry Laboratory. 2B1dH and its mutants were expressed in Escherichia coli TOPP3 (Stratagene) and purified as described (33Scott E.E. Spatzenegger M. Halpert J.R. Arch. Biochem. Biophys. 2001; 395: 57-68Crossref PubMed Scopus (126) Google Scholar). In brief, bacteria were grown in Terrific Broth salts for ∼2.5 h at 37 °C before induction using isopropyl-औ-d-thiogalactopyranoside and supplementation with the heme precursor δ-aminolevulinic acid. After 72 h at 30 °C, the cells were harvested by centrifugation, and protein was extracted from lysed membranes using potassium phosphate buffer (pH 7.4). Protein extract was loaded onto a Ni2+affinity column, which was washed with 20 volumes of buffer, and then eluted with 200 mm imidazole. Cytochrome P450 was quantitated using the reduced CO difference spectrum (35Omura T. Sato R. J. Biol. Chem. 1964; 239: 2379-2387Abstract Full Text PDF PubMed Google Scholar). Specific content was determined using the Pierce BCA kit with bovine serum albumin as a standard. The specific content for 2B1dH was 18 nmol of P450/mg of protein, whereas the specific content for most of the mutants was between 8 and 16. However, the I114A/F206V/S294D/F297G/V363L, I114A/F206V/S294D/F297G/V363L/I477F, and V103I/I114A/F206V/S294D/F297G/V363L/I477F multiple mutants had specific contents of 4, 5, and 2 nmol, respectively. Low specific content in these mutants is accounted for by the presence of significant amounts of P420. Progesterone and testosterone hydroxylation assays were carried out essentially as described (33Scott E.E. Spatzenegger M. Halpert J.R. Arch. Biochem. Biophys. 2001; 395: 57-68Crossref PubMed Scopus (126) Google Scholar, 36Ciaccio P.J. Halpert J.R. Arch. Biochem. Biophys. 1989; 271: 284-299Crossref PubMed Scopus (70) Google Scholar) using a 1:4:2 molar ratio of P450/cytochrome P450 reductase/cytochromeb5 in the absence of lipid. 16α- and 15α-hydroxyprogesterone were not resolved. However, the progesterone 16α-hydroxylase activity of 2B1 has been measured previously using two-dimensional chromatography (21Luo Z. He Y.A. Halpert J.R. Arch. Biochem. Biophys. 1994; 309: 52-57Crossref PubMed Scopus (48) Google Scholar). Km andkcat values were determined by regression analysis using Sigma Plot (Jandel Scientific, San Rafael, CA). A molecular model of P450 2B1 was constructed using the InsightII software package (Homology, Discover_3, Biopolymer, Builder, and Docking from Molecular Simulations Inc., San Diego, CA) and P450 2C5 as the template as described previously (24Spatzenegger M. Wang Q. He Y.Q. Wester M.R. Johnson E.F. Halpert J.R. Mol. Pharmacol. 2001; 59: 475-484Crossref PubMed Scopus (44) Google Scholar). For the 2B1 mutant (V103I/I114A/F206V/S294D/F297G/V363L/I477F), the coordinates of the corresponding residues were changed in the 2B1 three-dimensional model by Biopolymer, and the resulting 2B1 mutant was minimized. The structure of progesterone was constructed using the Builder module. The parameters for heme and ferryl oxygen were those described by Paulsen and Ornstein (37Paulsen M.D. Ornstein R.L. Proteins. 1991; 11: 184-204Crossref PubMed Scopus (83) Google Scholar, 38Paulsen M.D. Ornstein R.L. J. Comput. Aided Mol. Des. 1992; 6: 449-460Crossref PubMed Scopus (65) Google Scholar). During the docking calculations, the system energy minimization and molecular dynamics simulations were carried out with the Discover_3 program using the consistent valence force field with a non-bond cutoff of 10 Å to a maximum gradient of 5 kcal mol−1 Å−1. Progesterone was automatically docked into the three-dimensional models of 2B1 and V103I/I114A/F206V/S294D/F297G/V363L/I477F in a reactive binding orientation with the Docking module of InsightII, leading to 16α- or 21-hydroxylation. Because the initial oxidation step involves hydrogen abstraction, the C-16 or C-21 atom was placed 3.7 Å from ferryl oxygen, with the 16α-hydrogen or one of the hydrogen atoms bonded to C-21 directed toward ferryl oxygen (C-H-ferryl oxygen angle of 180°) to promote hydrogen bond formation. During the subsequent energy minimization process, the substrate molecule, along with the side chains of protein residues within 5 Å of the substrate, was allowed to move. The non-bond interaction energies were evaluated with the Docking module of InsightII, and the lowest energy orientation obtained after molecular mechanics minimization of 2B1 and its mutant is shown in Fig.6. 2B1dH single mutants were constructed at the nine active-site positions where 2B1 and 2C5 differ and tested for oxidation of progesterone. Consistent with previous findings, 2B1dH had negligible progesterone 21-hydroxylase activity, but significant progesterone 16α-hydroxylase activity (>2 min−1) at 150 ॖm progesterone (Fig.2), which was the highest substrate concentration obtainable under our conditions. However, the 2B1dH single mutants I114A, F297G, and V363L had 5–157 of 2C5dH progesterone 21-hydroxylase activity. With regard to progesterone 16α- and 15α-hydroxylation, the I114A mutant showed enhanced activity, whereas F297G and V363L showed decreased activity (Fig. 2). Although V363L demonstrated lower activity for progesterone 21-hydroxylation compared with I114A, it showed high regioselectivity for this reaction (>707). The F206V substitution yielded relatively high activity (6 min−1) and >957 regioselectivity for an unknown product (Fig. 2). The progesterone hydroxylation profile of V103I was similar to that of 2B1dH, whereas S294D, V367L, I477F, and G478V showed negligible progesterone hydroxylase activity. As shown in TableI, the Km for progesterone of 2B1dH was determined to be 200 ॖm. Mutants I114A and F297G showed a 3-fold decrease inKm, whereas V363L showed a 2-fold decrease. Interestingly, a F206V substitution decreased the Kmby ∼13-fold. The kcat values for progesterone 21-hydroxylation by I114A, F297G, and V363L were in the range of 1–2 min−1versus 16 min−1 for 2C5dH (Table I).Table ISteady-state kinetics of 2B1dH single mutants for progesterone 16α+15α- and 21-hydroxylase and unknown activities2B1dH mutantsProgesterone 16α+15α-hydroxylaseProgesterone 21-hydroxylaseUnknownKmkcatKmkcatKmkcatॖmmin−1ॖmmin−1ॖmmin−12B1dH200 ± 508 ± 22C5dH8 ± 116 ± 2.0I114A44 ± 914 ± 167 ± 71.8 ± 0.1F206V15 ± 37 ± 1F297G59 ± 121.2 ± 0.1V363L116 ± 262.0 ± 0.2Results are the means ± S.D. of three independent experiments. Open table in a new tab Results are the means ± S.D. of three independent experiments. A number of multiple mutants were constructed by combining I114A, F297G, and V363L to test the additive effect on progesterone 21-hydroxylase activity. In addition, F206V was also added to assess whether this mutation decreases the Km. The progesterone hydroxylation profiles of the multiple mutants are presented in Fig. 3. As expected, I114A/F297G (Fig. 3, A bars) showed enhanced progesterone 21-hydroxylase activity compared with either single mutant. Addition of V363L to I114A/F297G increased the regioselectivity for progesterone 21-hydroxylation, although activity was suppressed (Fig. 3,B bars versus A bars). Addition of F206V to I114A and I114A/V363L caused high activity for unknown products while suppressing progesterone 21- and 16α/15α-hydroxylase activities (Fig. 3, C and E bars). However, addition of F206V to I114/F297G did not suppress progesterone 21- and 16α/15α-hydroxylase activities (Fig. 3, D bars). Interestingly, addition of F206V to I114A/F297G/V363L enhanced activity for progesterone 21-hydroxylation and suppressed progesterone 16α- and 15α-hydroxylase activity, but still allowed significant production of unknown products (Fig. 3, F bars). Unlike 2B1dH, which produced only 16α-hydroxyprogesterone, and 2C5dH, which produced only 21-hydroxyprogesterone, the quadruple mutant I114A/F206V/F297G/V363L (Q) produced two major and two minor unknown products (Fig. 4). 21-Hydroxyprogesterone was determined to compose 577 of all the products in the quadruple mutant. I114A/F206V, I114A/F206V/F297F, and I114A/F206V/V363L had a decreased Km for progesteroneversus those mutants without Val206. TheKm for progesterone was unaltered in I114A/F297G and I114A/F297G/V363L compared with the individual single mutants (TableII), further suggesting the crucial role of F206V in enhancing the affinity for the substrate. Thekcat for the quadruple mutant was 607 of that for 2C5dH, and the Km was decreased by 3–4-fold compared with 2B1dH (Tables I and II). The 10-fold increase inkcat for progesterone 21-hydroxylation with no change in Km upon addition of F206V to I114A/F297G/V363L is striking and is different from other multiple mutants that include F206V.Figure 4Thin-layer chromatography of progesterone metabolites produced by 2B1dH, 2C5dH, and the 2B1dH quadruple mutant. The quadruple mutant is 2B1dH I114A/F206V/F297G/V363L.Unknown 3 is identical to the unknown obtained with F206V in Fig. 2. 16α- and 15α-hydroxyprogesterone co-migrate and were isolated together.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Table IISteady-state kinetics of 2B1dH multiple mutants for progesterone 21-hydroxylase and unknown activities2B1dH mutantsProgesterone 21-hydroxylaseUnknownKmkcatKmkcatॖmmin−1ॖmmin−1I114A/F206V26 ± 28.0 ± 0.2I114A/F297G94 ± 144.0 ± 0.3I114A/F206V/F297G30 ± 61.5 ± 0.125 ± 48.0 ± 0.5I114A/F206V/V363L36 ± 64.0 ± 0.3I114A/F297G/V363L68 ± 130.9 ± 0.1I114A/F206V/F297G/V363L66 ± 1610 ± 2.060 ± 103.0 ± 0.3Results are the means ± S.D. of three independent experiments. Open table in a new tab Results are the means ± S.D. of three independent experiments. Testosterone hydroxylation profiles were determined for 2B1dH single mutants and compared with those of 2B1dH and 2C5dH. As reported above, 2B1dH produced equal amounts of 16α- and 16औ-hydroxytestosterone, whereas 2C5dH demonstrated mainly testosterone 16औ-hydroxylase activity (Fig.5). Of the nine single mutants tested, S294D, V363L, and I477F had decreased testosterone 16α-hydroxylase activity and enhanced 16औ-hydroxylase activity (similar to 2C5dH). The Km of 2C5dH for testosterone (TableIII) was similar to the reportedKm of 2B1dH (39Scott E.E. He Y.Q. Halpert J.R. Chem. Res. Toxicol. 2002; 15: 1407-1413Crossref PubMed Scopus (38) Google Scholar). However, the S294D and I477F single mutants demonstrated a 2-fold lower Km for testosterone. Interestingly, F206V showed decreased 16α- and 16औ-testosterone hydroxylase activities and a new testosterone 6α-hydroxylase activity. This profile of testosterone hydroxylation is similar to the progesterone hydroxylation profile in that F206V primarily showed activity for a new product (Figs. 2 and 5). On the other hand, V103I showed unaltered testosterone hydroxylation, and F297G, V367L, and G478V showed decreased testosterone 16α- and 16औ-hydroxylase activities. The similar testosterone hydroxylation profiles and affinities for substrate of 2C5dH, S294D, and I477F suggested that addition of S294D and/or I477F to the 2B1dH quadruple mutant might enhance progesterone 21-hydroxylase activity and/or regioselectivity.Table IIISteady-state kinetics and regioselectivity for testosterone 16औ-hydroxylase activity of 2B1dH, 2C5dH, and 2B1dH single mutantsEnzyme16औ-HydroxylaseKmkcatRegioselectivityॖmmin−172B1dH3-aThese data were taken from Ref. 39.29 ± 44 ± 1.050 ± 42C5dH31 ± 318 ± 0.590 ± 3S294D14 ± 36 ± 0.488 ± 4I477F17 ± 66 ± 1.078 ± 3Results are the means ± S.D. of two independent experiments.3-a These data were taken from Ref. 39Scott E.E. He Y.Q. Halpert J.R. Chem. Res. Toxicol. 2002; 15: 1407-1413Crossref PubMed Scopus (38) Google Scholar. Open table in a new tab Results are the means ± S.D. of two independent experiments. Q/S294D, Q/I477F, and Q/S294D/I477F were examined for progesterone hydroxylation using 150 ॖmsubstrate (Table IV). Progesterone 21-hydroxylase activity was largely unaffected, whereas regioselectivity for Q/S294D, Q/S294D/I477F, and Q/I477F was increased to 73, 69, and 677, respectively, compared with 577 for the quadruple mutant. Steady-state kinetic parameters were also measured for these multiple mutants (Table IV). The kcat for Q/S294D and Q/S294D/I477F was similar to that for the quadruple mutant, but was increased for Q/I477F (similar to 2C5dH). However, theKm was either unaffected in the case of Q/S294D and Q/S294D/I477F or increased in the case of Q/I477F. These observations suggested that addition of S294D to the quadruple mutant increased regioselectivity for progesterone 21-hydroxylation, whereas I477F enhanced the activity as well as the regioselectivity. Thekcat and regioselectivity for progesterone 21-hydroxylation were much improved over those for the quadruple mutant and close to those for 2C5dH. To test further improvement of progesterone 21-hydroxylase activity and regioselectivity, the remaining three mutants (V103I, V367L, and G478V) were added to Q/I477F and Q/S294D/ I477F.Table IVProgesterone hydroxylation at 150 ॖm substrate and steady-state kinetics and regioselectivity for progesterone 21-hydroxylase activity2B1dH mutantsProgesterone hydroxylation4-aResults are the means of two independent experiments. The variation between experiments is not more than 57.Progesterone 21-hydroxylase activity4-bResults are the means ± S.D. of two independent experiments.16α + 15α21Unknowns4-cUnknown activity is the sum of four different products, as shown in Fig. 4.KmkcatRegioselectivitymin−1ॖmmin−17Quadruple (Q)0.056.84.6966 ± 1610 ± 257 ± 2Q/S294D0.276.301.9864 ± 59 ± 173 ± 3Q/I477F0.168.804.02135 ± 818 ± 167 ± 2Q/S294D/I477F0.456.302.2474 ± 712 ± 169 ± 34-a Results are the means of two independent experiments. The variation between experiments is not more than 57.4-b Results are the means ± S.D. of two independent experiments.4-c Unknown activity is the sum of four different products, as shown in Fig. 4. Open table in a new tab Q/V103I/I477F and Q/V103I/S294D/I477F showed ∼807 regioselectivity for progesterone 21-hydroxylation (Table V). Thekcat for progesterone 21-hydroxylation by Q/V103I/I477F and Q/V103I/S294D/I477F was 1.5- and 3-fold higher than that for 2C5dH, respectively. The Km for progesterone was largely unchanged from that of the mutants lacking V103I (Table Vversus Table IV). Addition of S294D to Q/I477F and Q/V103I/I477F yielded high P420, as described under “Experimental Procedures,” whereas addition of S294D/V367L to Q/V103I/I477F and Q/V103I/I477F/G478V yielded only P420 (data not shown). As expected based on the V367L and G478V single mutants, Q/V103I/V367L/I477F, Q/V103I/I477F/G478V, and Q/V103I/S294D/I477F/G478V showed much lower activity and regioselectivity for progesterone 21-hydroxylation compared with Q/V103I/I477F and Q/V103I/S294D/I477F (Table V). The Km for substrate was not substantially affected compared with Q/V103I/I477F and Q/V103I/S294D/I477F.Table VProgesterone hydroxylation at 150 ॖm substrate and steady-state kinetics and regioselectivity for progesterone 21-hydroxylase activity2B1dH mutantsProgesterone hydroxylation5-aResults are the means of two independent experiments. The variation between experiments is not more than 57.Progesterone 21-hydroxylase activity5-bResults are the means ± S.D. of two independent experiments.16α + 15α21Unknowns5-cUnknown activity is the sum of four different products, as shown in Fig. 4.KmkcatRegioselectivitymin−1ॖmmin−1Q/V103I/I477F0.3713.112.88135 ± 926 ± 1.078 ± 2Q/V103I/S294D/I477F3.2428.203.87131 ± 1054 ± 2.078 ± 2Q/V103I/V367L/I477F0.844.535.8198 ± 914 ± 1.040 ± 2Q/V103I/I477F/G478V0.002.062.18117 ± 104 ± 0.248 ± 2Q/V103I/S294D/I477F/G478V0.001.790.9961 ± 52.1 ± 0.164 ± 2Q/V103I/S294D/V367L/I477F and Q/V103I/S294D/V367L/I477F/G478V do not express.5-a Results are the means of two independent experiments. The variation between experiments is not more than 57.5-b Results are the means ± S.D. of two independent experiments.5-c Unknown activity is the sum of four different products, as shown in Fig. 4. Open table in a new tab Q/V103I/S294D/V367L/I477F and Q/V103I/S294D/V367L/I477F/G478V do not express. To explain the changes in regioselectivity observed for progesterone in 2B1 Q/V103I/S294D/I477F, a molecular model was constructed. Fig.6 (A and B) shows progesterone docked into the active site of the wild-type 2B1 and 2B1 Q/V103I/S294D/I477F models, respectively. The substrate fit well in the wild-type 2B1 active site, with no van der Waals overlaps when docked in an orientation that leads to formation of 16α-hydroxyprogesterone (Fig. 6A). However, the substrate did not fit in a 21-OH orientation. The estimated angle (C-H-ferryl oxygen) and distance (between C-16 and ferryl oxygen) in 2B1 are 153.0° and 4.43 Å, respectively. Active-site residues Ile114, Phe206, Phe297, Val363, and Ile477 are within 5 Å of the substrate. In contrast, progesterone fit well in the 2B1 Q/V103I/S294D/I477F active site when docked in a 21-OH orientation, but not in a 16α-OH orientation (Fig.6B). The estimated angle (C-H-ferryl oxygen) and distance (between C-21 and ferryl oxygen) are 160.6° and 3.69 Å, respectively. These are close to the angle and distance required for hydrogen bond formation (180° and 3.7 Å, respectively) and are similar to those for 2C5 (Ref. 1Williams P.A. Cosme J. Sridhar V. Johnson E.F. McRee D.E. Mol. Cell. 2000; 5: 121-131Abstract Full Text Full Text PDF PubMed Scopus (710) Google Scholar and data not shown). Active-site residues Ile103, Ala114, Val206, Asp294, Gly297, Leu363, and Phe477 are within 5 Å of the substrate, with Ala114 and Phe477 lying closest at 3 Å. Our modeling results are consistent with the biochemical data that 2B1 favors 16α-hydroxylation, whereas 2B1 Q/V103I/S294D/I477F favors the formation of 21-hydroxyprogesterone. Consistent with the experimental data, modeling of progesterone in 2B1 mutants that included V367L and/or G478V along with Q/V103I/S294D/I477F showed poor fits (data not shown). This suggests that V367L and G478V mutations, either individually or in combination with others, change the active-site structure in a way that is unfavorable for progesterone 21-hydroxylation. The recent elucidation of the x-ray crystal structure of the first mammalian P450 (rabbit 2C5) has sparked intense interest in understanding the structural basis of P450 function to facilitate drug discovery/design and engineering of novel biocatalysts (1Williams P.A. Cosme J. Sridhar V. Johnson E.F. McRee D.E. Mol. Cell. 2000; 5: 121-131Abstract Full Text Full Text PDF PubMed Scopus (710) Google Scholar). This breakthrough has led to advanced homology models of drug-metabolizing cytochromes P450, especially the enzymes from the P450 2 subfamily, relative to those constructed based on bacterial enzymes (25Lewis D.F.V. J. Inorg. Biochem. 2002; 91: 502-514Crossref PubMed Scopus (33) Google Scholar). The P450 2C5 crystal structure has also provided an enhanced framework for identifying active-site residues and investigating their role in differential substrate specificities and stereo- and regioselectivity across subfamilies (2Domanski T.L. Halpert J.R. Curr. Drug Metab. 2001; 2: 117-137Crossref PubMed Scopus (153) Google Scholar, 22Spatzenegger M. Liu H. Wang Q. Debarber A. Koop D.R. Halpert J.R. J. Pharmacol. Exp. Ther. 2003; 304: 477-487Crossref PubMed Scopus (65) Google Scholar). By extensive site-directed mutagenesis studies and more recently by analogy with 2C5, 13 2B1 active-site residues have been identified, nine of which differ from those of 2C5 (2Domanski T.L. Halpert J.R. Curr. Drug Metab. 2001; 2: 117-137Crossref PubMed Scopus (153) Google Scholar). In the present study, 2B1 residues have been replaced systematically by the corresponding active-site residues of 2C5 to confer a novel progesterone hydroxylase activity (progesterone 21-hydroxylation). The major finding is that simultaneous substitution of seven 2B1 active-site residues (positions 103, 114, 206, 294, 297, 363, and 477) with the corresponding 2C5 residues resulted in a 3-fold higherkcat for progesterone 21-hydroxylation compared with 2C5 with 807 regioselectivity. However, the Kmfor the substrate remained an order of magnitude higher than that for 2C5. Consistent with the experimental data, substrate docking in the active site of a model of the multiple mutant showed that the formation of 21-hydroxyprogesterone is favored, unlike wild-type 2B1, which favors 16α-hydroxyprogesterone. To produce a 2B1 multiple mutant with the desired phenotype, a three-tiered approach was used. First, 2B1 single mutants were made at all nine non-identical active-site positions, and three mutants that showed progesterone 21-hydroxylation (I114A, F297G, and V363L) and a fourth with a decreasedKm (F206V) were combined to yield a quadruple mutant. Second, additional substitutions (S294D and I477F) were added based on a 2C5-like testosterone hydroxylation profile. Finally, V103I, which had no effect on progesterone or testosterone hydroxylation profiles on its own, was added to Q/S294D/ I477F. New insights can be gained by comparing and contrasting the present study with our recent investigation of active-site determinants of specificity differences between P450 2B6 and 2E1 (22Spatzenegger M. Liu H. Wang Q. Debarber A. Koop D.R. Halpert J.R. J. Pharmacol. Exp. Ther. 2003; 304: 477-487Crossref PubMed Scopus (65) Google Scholar). In that case, a single point mutation at the alignment position corresponding to residue 477 in 2B enzymes conferred on 2E1 significant activity for the 2B6-selective substrate 7-ethoxy-4-trifluoromethylcoumarin and abolished activity for the 2E1-selective substratep-nitrophenol. However, none of six 2B6 single mutants gained activity for p-nitrophenol. The two major advances in this investigation were the focus on regioselectivity differences for a common substrate, progesterone, and the generation of multiple 2B mutants, many of which included substitutions that, on their own, did not enhance the activity of interest. Based on the results, it appears that, in addition to direct interactions of active-site residues with substrate, residue-residue interactions and/or an influence of active-site backbone residues on orientation of the substrate may also be important (4Haseman C.A. Kurumbail R.G. Boddupalli S.S. Peterson J.A. Deisenhofer J. Structure. 1995; 3: 41-62Abstract Full Text Full Text PDF PubMed Scopus (642) Google Scholar, 24Spatzenegger M. Wang Q. He Y.Q. Wester M.R. Johnson E.F. Halpert J.R. Mol. Pharmacol. 2001; 59: 475-484Crossref PubMed Scopus (44) Google Scholar). Residue-residue interactions have been implicated in determining stereo- and regioselectivity for androstenedione hydroxylation and differential inhibition by 4-phenylimidazole in 2B4 and 2B5 (7He Y.Q. Szklarz G.D. Halpert J.R. Arch. Biochem. Biophys. 1996; 335: 152-160Crossref PubMed Scopus (31) Google Scholar, 24Spatzenegger M. Wang Q. He Y.Q. Wester M.R. Johnson E.F. Halpert J.R. Mol. Pharmacol. 2001; 59: 475-484Crossref PubMed Scopus (44) Google Scholar). For example, mutagenesis experiments and molecular modeling suggest that the side chains of residues 114 and 294 in 2B4 and 2B5 move in concert to influence the 4-phenylimidazole binding orientation (24Spatzenegger M. Wang Q. He Y.Q. Wester M.R. Johnson E.F. Halpert J.R. Mol. Pharmacol. 2001; 59: 475-484Crossref PubMed Scopus (44) Google Scholar). In the present case, there were increases in progesterone 21-hydroxylase activity of 10-, 2-, and 3-fold upon addition of F206V to I114A/F297G/V363L, I477F to I114A/F206V/F297G/V363L, and V103I to Q/I477F, respectively, even though F206V, I477F, and V103I alone showed negligible progesterone 21-hydroxylase activity. These observations may reflect an additional interaction between Phe477 and/or Phe206 and progesterone that leads to tighter packing in the active site and an increased frequency of productive collisions (Fig. 6). Ile103 is also closer to progesterone in Q/V103I/S294D/I477F compared with 2B1. The almost complete conversion of stereoselectivity for testosterone 16-hydroxylation by 2B1 S294D, V363L, and I477F to that of 2C5 aided in making multiple mutants with higher progesterone 21-hydroxylase activity and regioselectivity. However, it should be recognized that the 2C5-like testosterone hydroxylation profiles of S294D, V367L, and I477F resulted from abolished testosterone 16α-hydroxylase activity and enhanced 16औ-hydroxylase activity, rather than acquisition of a novel activity as with progesterone 21-hydroxylation by I114A, F297G, and V363L. There are numerous prior examples of stereoselective loss of activity upon single amino acid substitutions in bacterial and mammalian P450 enzymes (28Halpert J.R. He Y.A. J. Biol. Chem. 1993; 268: 4453-4457Abstract Full Text PDF PubMed Google Scholar, 40Lindberg R.L. Negishi M. Nature. 1989; 339: 632-634Crossref PubMed Scopus (368) Google Scholar, 41Uno T. Mitchell E. Aida K. Lambert M.H. Darden T.A. Pedersen L.G. Negishi M. Biochemistry. 1997; 36: 3193-3198Crossref PubMed Scopus (17) Google Scholar). On the other hand, F206V exhibited a novel activity with both progesterone and testosterone along with greatly suppressed original activities. Residue 206 in 2B1 has previously been shown to be critical in converting steroid 16- to 15α-hydroxylation (21Luo Z. He Y.A. Halpert J.R. Arch. Biochem. Biophys. 1994; 309: 52-57Crossref PubMed Scopus (48) Google Scholar), and the analogous residue in 2a4 and 2a5 is a major determinant of differences in substrate specificity (40Lindberg R.L. Negishi M. Nature. 1989; 339: 632-634Crossref PubMed Scopus (368) Google Scholar). The F205V substitution in 2C5 results in almost a complete loss of progesterone 21-hydroxylase activity and gain of new activity, suggesting that this residue is critical in determining P450 regioselectivity (26Cosme J. Johnson E.F. J. Biol. Chem. 2000; 275: 2545-2553Abstract Full Text Full Text PDF PubMed Scopus (160) Google Scholar). However, the structural basis for these observations remains unclear. In the absence of deleterious steric interactions with 2B1, the more hydrophobic progesterone should be characterized by a lowerKm compared with testosterone, as observed with 2C5. However, wild-type 2B1 exhibited a 7-fold higher Kmfor progesterone than for testosterone. This suggests that the larger 17औ-acetyl group in progesterone, as opposed to the hydroxyl group in testosterone, clashes with one or more residues in the 2B1 active site. Furthermore, a F206V substitution in 2B1, either individually or in combination with I114A, I114A/F297G, or I114A/V363L, decreased theKm for progesterone by 6–13-fold, suggesting a major role of Val206 in determining affinity. Other multiple mutants that included F206V exhibited an increasedKm, which may be due to the occurrence of additional unfavorable interactions. The Km is generally affected by parameters such as size, shape, and hydrophobicity of the substrate and of active-site residues (42Negishi M. Uno T. Darden T.A. Sueyoshi T. Pedersen L.G. FASEB J. 1996; 10: 683-689Crossref PubMed Scopus (67) Google Scholar). A similar Phe-to-Val substitution at residue 226 in P450 1A2 (analogous to residue 206 in 2B1) has also been shown to have a strong bearing on substrate affinity (43Parikh A. Josephy P.D. Guengerich F.P. Biochemistry. 1999; 38: 5283-5289Crossref PubMed Scopus (111) Google Scholar). An excellent correlation has been observed betweenKm values and side chain size at residue 209 in P450 2a5 (analogous to residue 206 in 2B1), in which theKm values decrease as the side chains become larger regardless of the hydrophobicity (44Juvonen R.O. Iwasaki M. Negishi M. J. Biol. Chem. 1991; 266: 16431-16435Abstract Full Text PDF PubMed Google Scholar). The larger side chain of Phe206 in 2B1 may interact sterically with the additional acetyl group in progesterone compared with testosterone (Fig. 6) (1Williams P.A. Cosme J. Sridhar V. Johnson E.F. McRee D.E. Mol. Cell. 2000; 5: 121-131Abstract Full Text Full Text PDF PubMed Scopus (710) Google Scholar). The F206V substitution may provide more room for entry in a particular orientation leading to increased affinity for substrate. In summary, our results demonstrate that active-site residues are mainly responsible for determining differences in regioselectivity for progesterone hydroxylation between 2B1 and 2C5. A synergistic effect on progesterone 21-hydroxylation activity and regioselectivity by certain multiple substitutions suggests a role of residue-residue interactions in determining active-site topology and substrate orientation. This report suggests the feasibility of rational redesign of mammalian P450 specificity based on analogy with P450 2C5, as previously performed for bacterial P450 enzymes of known three-dimensional structure (45Miles C.S. Ost T.W.B. Noble M.A. Munro A.W. Chapman S.K. Biochim. Biophys. Acta. 2000; 1543: 383-407Crossref PubMed Scopus (62) Google Scholar). This approach provides an excellent complement to directed evolution by random mutagenesis, which tends to mainly pinpoint non-active-site residues (46Farinas E.T. Bulter T. Arnold F.H. Curr. Opin. Biotechnol. 2001; 12: 545-551Crossref PubMed Scopus (232) Google Scholar, 47Cirino P.C. Arnold F.H. Curr. Opin. Chem. Biol. 2002; 6: 130-135Crossref PubMed Scopus (108) Google Scholar). We thank Drs. Tammy L. Domanski, Kishore K. Khan, and Dmitri R. Davydov and You Qun He for invaluable help while pursuing this work and preparing the manuscript. We also thank Dr. Eric F. Johnson for providing a P450 2C5dH protein sample." @default.
• W2077286010 created "2016-06-24" @default.
• W2077286010 creator A5012368572 @default.
• W2077286010 creator A5033645297 @default.
• W2077286010 creator A5062112321 @default.
• W2077286010 creator A5068270554 @default.
• W2077286010 date "2003-05-01" @default.
• W2077286010 modified "2023-10-16" @default.
• W2077286010 title "A Rational Approach to Re-engineer Cytochrome P450 2B1 Regioselectivity Based on the Crystal Structure of Cytochrome P450 2C5" @default.
• W2077286010 cites W1498652161 @default.
• W2077286010 cites W1516052403 @default.
• W2077286010 cites W1532168967 @default.
• W2077286010 cites W1532212858 @default.
• W2077286010 cites W1533372435 @default.
• W2077286010 cites W1534606074 @default.
• W2077286010 cites W1547482025 @default.
• W2077286010 cites W1612382250 @default.
• W2077286010 cites W1898420966 @default.
• W2077286010 cites W1959032446 @default.
• W2077286010 cites W1982406750 @default.
• W2077286010 cites W1985820167 @default.
• W2077286010 cites W1987687892 @default.
• W2077286010 cites W1998858855 @default.
• W2077286010 cites W1999169234 @default.
• W2077286010 cites W2005167964 @default.
• W2077286010 cites W2005498416 @default.
• W2077286010 cites W2008578035 @default.
• W2077286010 cites W2008984280 @default.
• W2077286010 cites W2012271559 @default.
• W2077286010 cites W2022246634 @default.
• W2077286010 cites W2026069866 @default.
• W2077286010 cites W2032348454 @default.
• W2077286010 cites W2032818617 @default.
• W2077286010 cites W2034292494 @default.
• W2077286010 cites W2035330965 @default.
• W2077286010 cites W2041251099 @default.
• W2077286010 cites W2046523342 @default.
• W2077286010 cites W2051639214 @default.
• W2077286010 cites W2051649196 @default.
• W2077286010 cites W2052947697 @default.
• W2077286010 cites W2054900334 @default.
• W2077286010 cites W2058078099 @default.
• W2077286010 cites W2058698055 @default.
• W2077286010 cites W2060667909 @default.
• W2077286010 cites W2062683863 @default.
• W2077286010 cites W2087699848 @default.
• W2077286010 cites W2106411950 @default.
• W2077286010 cites W2126592776 @default.
• W2077286010 cites W2126864745 @default.
• W2077286010 cites W2135531711 @default.
• W2077286010 cites W2137300266 @default.
• W2077286010 cites W4255632666 @default.
• W2077286010 doi "https://doi.org/10.1074/jbc.m212515200" @default.
• W2077286010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12609983" @default.
• W2077286010 hasPublicationYear "2003" @default.
• W2077286010 type Work @default.
• W2077286010 sameAs 2077286010 @default.
• W2077286010 citedByCount "51" @default.
• W2077286010 countsByYear W20772860102012 @default.
• W2077286010 countsByYear W20772860102015 @default.
• W2077286010 countsByYear W20772860102016 @default.
• W2077286010 countsByYear W20772860102017 @default.
• W2077286010 countsByYear W20772860102018 @default.
• W2077286010 countsByYear W20772860102019 @default.
• W2077286010 countsByYear W20772860102020 @default.
• W2077286010 countsByYear W20772860102022 @default.
• W2077286010 crossrefType "journal-article" @default.
• W2077286010 hasAuthorship W2077286010A5012368572 @default.
• W2077286010 hasAuthorship W2077286010A5033645297 @default.
• W2077286010 hasAuthorship W2077286010A5062112321 @default.
• W2077286010 hasAuthorship W2077286010A5068270554 @default.
• W2077286010 hasBestOaLocation W20772860101 @default.
• W2077286010 hasConcept C161790260 @default.
• W2077286010 hasConcept C178790620 @default.
• W2077286010 hasConcept C181199279 @default.
• W2077286010 hasConcept C185592680 @default.
• W2077286010 hasConcept C2780768313 @default.
• W2077286010 hasConcept C526171541 @default.
• W2077286010 hasConcept C59759590 @default.
• W2077286010 hasConcept C71240020 @default.
• W2077286010 hasConceptScore W2077286010C161790260 @default.
• W2077286010 hasConceptScore W2077286010C178790620 @default.
• W2077286010 hasConceptScore W2077286010C181199279 @default.
• W2077286010 hasConceptScore W2077286010C185592680 @default.
• W2077286010 hasConceptScore W2077286010C2780768313 @default.
• W2077286010 hasConceptScore W2077286010C526171541 @default.
• W2077286010 hasConceptScore W2077286010C59759590 @default.
• W2077286010 hasConceptScore W2077286010C71240020 @default.
• W2077286010 hasIssue "19" @default.
• W2077286010 hasLocation W20772860101 @default.
• W2077286010 hasOpenAccess W2077286010 @default.
• W2077286010 hasPrimaryLocation W20772860101 @default.
• W2077286010 hasRelatedWork W1977450780 @default.
• W2077286010 hasRelatedWork W1979916757 @default.
• W2077286010 hasRelatedWork W1981122053 @default.
• W2077286010 hasRelatedWork W1981902716 @default.
• W2077286010 hasRelatedWork W2025363956 @default.
• W2077286010 hasRelatedWork W2950931415 @default.

• next